Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Evaluation of Two Dosing Regimens for Nivolumab in Combin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
0
Authors
Célèste Lebbe
18 more
Célèste Lebbe
•
Paolo Ascierto
16 more
•
Jacopo Pigozzo
Published
February 27, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Clinical Oncology
Topics
Physics
Optics
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1200/jco.18.01998
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Clinical Oncology
Topics
Physics
Optics
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1200/jco.18.01998
License
CC-BY-NC-ND
Other Formats
PDF
